1
|
Adorjan K, Schulze TG, Budde M, Heilbronner U, Tessema F, Mekonnen Z, Falkai P. [Neurogenetics of schizophrenia: findings from studies based on data sharing and global partnerships]. DER NERVENARZT 2021; 92:199-207. [PMID: 33439287 DOI: 10.1007/s00115-020-01052-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 12/07/2020] [Indexed: 11/25/2022]
Abstract
Schizophrenic psychoses are the result of a multifactorial process in which not only environmental influences but also genetic factors play an important role. These factors are based on a complex mode of inheritance that involves a large number of genetic variants. In the last three decades, biological psychiatric research has focused closely on molecular genetic aspects of the hereditary basis of schizophrenic psychoses. In particular, international consortia are combining cohorts from individual researchers, creating continuously increasing sample sizes and thus increased statistical power. As part of the Psychiatric Genomics Consortium (PGC), genome-wide association studies with tens of thousands of patients and controls have for the first time found robustly replicable markers for schizophrenic psychoses. Through intensive phenotyping, first approaches to a transdiagnostic clinical reclassification of severe mental illnesses have been established in the longitudinal PsyCourse study of the UMG Göttingen and the LMU Munich, allowing new biologically validated disease subgroups with prognostic value to be identified. For the first time environmental factors could even be examined in an African cohort that contribute to the development of the psychosis. In the coming years, the enormous technical progress in the area of genomic high-throughput technologies (next-generation sequencing) is expected to provide new knowledge not only about the influence of frequently occurring single nucleotide polymorphisms but also about rare variants. For the successful use of this technological revolution an exchange of data between research groups is essential.
Collapse
Affiliation(s)
- K Adorjan
- Klinik für Psychiatrie und Psychotherapie, LMU Klinikum, Nussbaumstr. 7, 80336, München, Deutschland.
- Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, München, Deutschland.
- Center for International Health (CIH), LMU Munich, München, Deutschland.
| | - T G Schulze
- Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, München, Deutschland
| | - M Budde
- Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, München, Deutschland
| | - U Heilbronner
- Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, München, Deutschland
| | - F Tessema
- Department of Epidemiology, Faculty of Public Health, Gilgel Gibe Filed Research Center, Jimma University, Jimma, Äthiopien
| | - Z Mekonnen
- School of Medical Laboratory Sciences, Institute of Health, Jimma University, Jimma, Äthiopien
| | - P Falkai
- Klinik für Psychiatrie und Psychotherapie, LMU Klinikum, Nussbaumstr. 7, 80336, München, Deutschland
| |
Collapse
|